Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.
3.

Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.

Simons JW, Carducci MA, Mikhak B, Lim M, Biedrzycki B, Borellini F, Clift SM, Hege KM, Ando DG, Piantadosi S, Mulligan R, Nelson WG.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3394-401.

4.

Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.

Luiten RM, Kueter EW, Mooi W, Gallee MP, Rankin EM, Gerritsen WR, Clift SM, Nooijen WJ, Weder P, van de Kasteele WF, Sein J, van den Berk PC, Nieweg OE, Berns AM, Spits H, de Gast GC.

J Clin Oncol. 2005 Dec 10;23(35):8978-91. Epub 2005 Oct 31.

PMID:
16260696
5.
6.

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.

Nelson WG, Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Kim M, Weber CE, Baccala AA, Goeman MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF.

Cancer Chemother Pharmacol. 2000;46 Suppl:S67-72.

PMID:
10950151
7.

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF, Nelson WG.

Cancer Res. 1999 Oct 15;59(20):5160-8.

8.

Factors associated with gay men's sexual behaviours and risk on holiday.

Clift SM, Forrest SP.

AIDS Care. 1999 Jun;11(3):281-95.

PMID:
10474628
9.

Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer.

Baccala AA, Zhong H, Clift SM, Nelson WG, Marshall FF, Passe TJ, Gambill NB, Simons JW.

Urology. 1998 Feb;51(2):327-32.

PMID:
9495722
10.

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

Simons JW, Jaffee EM, Weber CE, Levitsky HI, Nelson WG, Carducci MA, Lazenby AJ, Cohen LK, Finn CC, Clift SM, Hauda KM, Beck LA, Leiferman KM, Owens AH Jr, Piantadosi S, Dranoff G, Mulligan RC, Pardoll DM, Marshall FF.

Cancer Res. 1997 Apr 15;57(8):1537-46.

11.

Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.

Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z.

J Cell Biol. 1994 May;125(3):681-93. Erratum in: J Cell Biol 1996 Feb;132(4):following 752.

12.

Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.

Schultz JR, Gong EL, McCall MR, Nichols AV, Clift SM, Rubin EM.

J Biol Chem. 1992 Oct 25;267(30):21630-6.

13.

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM.

Nature. 1991 Sep 19;353(6341):265-7.

PMID:
1910153
14.

Hypoxia-induced in vivo sickling of transgenic mouse red cells.

Rubin EM, Witkowska HE, Spangler E, Curtin P, Lubin BH, Mohandas N, Clift SM.

J Clin Invest. 1991 Feb;87(2):639-47.

16.

Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.

Carlson JA, Rogers BB, Sifers RN, Finegold MJ, Clift SM, DeMayo FJ, Bullock DW, Woo SL.

J Clin Invest. 1989 Apr;83(4):1183-90.

17.

Tissue-specific regulation of human alpha 1-antitrypsin gene expression in transgenic mice.

Shen RF, Clift SM, DeMayo JL, Sifers RN, Finegold MJ, Woo SL.

DNA. 1989 Mar;8(2):101-8.

PMID:
2784378
18.

Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice.

Sifers RN, Carlson JA, Clift SM, DeMayo FJ, Bullock DW, Woo SL.

Nucleic Acids Res. 1987 Feb 25;15(4):1459-75.

19.

The rat casein multigene family. Fine structure and evolution of the beta-casein gene.

Jones WK, Yu-Lee LY, Clift SM, Brown TL, Rosen JM.

J Biol Chem. 1985 Jun 10;260(11):7042-50.

20.

Evidence for genetically independent allosteric regulatory domains of the protein M1 subunit of mouse ribonucleotide reductase.

Eriksson S, Gudas LJ, Clift SM, Caras IW, Ullman B, Martin DW Jr.

J Biol Chem. 1981 Oct 10;256(19):10193-7.

21.

DeoxyATP-resistant ribonucleotide reductase of mutant mouse lymphoma cells. Evidence for heterozygosity for the protein M1 subunits.

Eriksson S, Gudas LJ, Ullman B, Clift SM, Martin DW Jr.

J Biol Chem. 1981 Oct 10;256(19):10184-8. No abstract available.

22.

Alterations in deoxyribonucleotide metabolism in cultured cells with ribonucleotide reductase activities refractory to feedback inhibition by 2'-deoxyadenosine triphosphate.

Ullman B, Clift SM, Gudas LJ, Levinson BB, Wormsted MA, Martin DW Jr.

J Biol Chem. 1980 Sep 10;255(17):8308-14. No abstract available.

23.

Abnormal regulation of purine metabolism in a cultured mouse T-cell lymphoma mutant partially deficient in adenylosuccinate synthetase.

Ullman B, Wormsted MA, Levinson BB, Gudas LJ, Cohen A, Clift SM, Martin DW Jr.

Adv Exp Med Biol. 1980;122A:375-86.

PMID:
6158849
24.

Abnormal regulation of de novo purine synthesis and purine salvage in a cultured mouse T-cell lymphoma mutant partially deficient in adenylosuccinate synthetase.

Ullman B, Clift SM, Cohen A, Gudas LJ, Levinson BB, Wormsted MA, Martin DW Jr.

J Cell Physiol. 1979 Apr;99(1):139-51.

PMID:
222775
26.

Characterization of mutant subunits of human purine nucleoside phosphorylase.

Gudas LJ, Zannis VI, Clift SM, Ammann AJ, Staal GE, Martin DW Jr.

J Biol Chem. 1978 Dec 25;253(24):8916-24. No abstract available.

Supplemental Content

Loading ...
Support Center